The University of Chicago Header Logo

Connection

Ernst Lengyel to Organoplatinum Compounds

Back to Details
This is a "connection" page, showing publications Ernst Lengyel has written about Organoplatinum Compounds.
Ernst Lengyel
Connection Strength
0.021
Organoplatinum Compounds
  1. A phase II, single-arm study of the anti-a5ß1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer. Gynecol Oncol. 2011 May 01; 121(2):273-9.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.